Siemens debuts tissue harmonic imaging

Article

Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra

Siemens Ultrasound of Issaquah, WA, has become the latest ultrasound vendor to add tissue harmonic imaging capabilities to its product line. The firm's version, called Ensemble Tissue Harmonic Imaging, will be offered on its premium Sonoline Elegra ultrasound scanners.

The new release allows Elegra users to isolate harmonic signal data without the use of contrast agents, according to the firm. Ensemble supports high-frequency imaging and can provide demonstration of breast lesions and superficial images. The system also shows promise in scanning difficult-to-image patients.

Ensemble eliminates the impact of signal artifacts common during high-frequency scanning with its pulse-inversion technology, which isolates harmonic imaging signals, according to Siemens. Combining the harmonic imaging signals with fundamental signal data allows Elegra to yield improvements in tissue contrast and spatial resolution in nearly all radiological applications, the company believes.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.